Correlation Between NYSE Composite and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Akero Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Akero Therapeutics.
Diversification Opportunities for NYSE Composite and Akero Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and Akero is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Akero Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Akero Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 3.66 times less return on investment than Akero Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 5.52 times less risky than Akero Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Akero Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 2,867 in Akero Therapeutics on August 24, 2024 and sell it today you would earn a total of 253.00 from holding Akero Therapeutics or generate 8.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Akero Therapeutics
Performance |
| Timeline |
NYSE Composite and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Akero Therapeutics
Pair trading matchups for Akero Therapeutics
Pair Trading with NYSE Composite and Akero Therapeutics
The main advantage of trading using opposite NYSE Composite and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| NYSE Composite vs. Awilco Drilling PLC | NYSE Composite vs. AKITA Drilling | NYSE Composite vs. SunOpta | NYSE Composite vs. Delek Drilling |
| Akero Therapeutics vs. Lyra Therapeutics | Akero Therapeutics vs. Hookipa Pharma | Akero Therapeutics vs. Cingulate Warrants | Akero Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |